Pelthos Therapeutics Inc. PTHS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| -$43.32M-445% | -$7.96M-7.8% | -$7.38M-200% | ||
| —— | $0— | —— | ||
| $5.46M+204% | $1.8M+3.8% | $1.73M+1,474% | ||
| -$22.59M-290% | -$5.79M-490% | -$981.03K+37.4% | ||
| —— | $0— | —— | ||
| $2.76M— | $0— | —— | ||
| —— | $0— | —— | ||
| $693K+29.3% | $536K— | —— | ||
| $45.34M— | —— | $1.02M-37.0% | ||
| $17.51M— | —— | $41.32K-25.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pelthos Therapeutics Inc. generate?
- Pelthos Therapeutics Inc. (PTHS) generated -$35.1M in operating cash flow over the trailing twelve months.
- What is Pelthos Therapeutics Inc.'s free cash flow?
- After $194.0K of capital expenditures, Pelthos Therapeutics Inc.'s free cash flow was -$16.8M over the trailing twelve months.
- Where does Pelthos Therapeutics Inc.'s cash flow data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
